- Added to Email Alerts
Non-Hodgkin Lymphoma
Latest News View All
-
Cancer Transplant Pioneers Model 'Team Science' -
New Combo Therapy for Breast Implant–Associated Lymphoma
-
Antibody Therapy Effective in Immunodeficient COVID-19 Patients
-
ASH 2021CAR T Cell Disappoints as Second-line for NHL in Phase 3 Trial
-
Progression of Large B-cell Lymphoma Cut 27% by Addition of Polatuzumab Vedotin
-
AP-NORC Poll: Omicron Raises COVID Worry but Not Precautions
-
ASH 2021'Outstanding Data': Mosunetuzumab in R/R Follicular Lymphoma
-
ASH 2021'Remarkable' Results With CAR T Cells Could Make Chemo Obsolete
Perspective View All
Journal Articles View All
-
Malignancy Risk in Patients With Secukinumab-treated Psoriasis
-
Diagnostic Workup, Etiology of Hypercalcemia of Malignancy
-
Risk of Severe Clinical Events After DAA Therapy in HIV/HCV
-
Immune Checkpoint Inhibitor Treatment Toxicity Risk in RA
-
Radiological Case: Primary Breast Lymphoma
-
Benefit of 5ASA Use After Anti-TNF or Immunomodulator in IBD
Additional Resources
Medscape Drugs & Diseases
- Non-Hodgkin Lymphoma
- Pediatric Non-Hodgkin Lymphoma
- B-Cell Lymphoma
- Diffuse Large Cell Lymphoma
- High-Grade Malignant Immunoblastic Lymphoma
Medscape Education